When Your Symptoms Don't Show Up on a Test
There is a stretch in which you feel unwell and every test says you are fine. It has a name, and knowing it changes the conversation you can have with your care team.
By Laura Carfang, Ed.D. EDUCATION | SURGERY
When Your Symptoms Don't Show Up on a Test
You know something has changed. The fatigue is not the ordinary kind. There is a heaviness, or a tightness, or a headache that keeps returning. You bring it up, and the workup comes back clean.
So you are sent to someone else. Then someone else. Each visit begins again from the top, and each one ends with a version of the same sentence: your labs look good.
At SurvivingBreastCancer.org we hear this constantly, and the detail that comes up again and again is not pain. It is the feeling of not being believed — or, more precisely, of not being measurable. Nobody has told you that you are imagining it. They have simply run out of tests to run.
That stretch has a name. It is not a diagnosis, and naming it does not explain what is happening in any particular body. But it does something useful: it gives you language for a real clinical situation, instead of leaving you to wonder whether the problem is you.
Listen Now
The prodromal phase
On a recent episode of Breast Cancer Conversations, Dr. Robert Whitfield, a plastic and reconstructive surgeon in Austin who spent fifteen years in cancer reconstruction, described it in a way that landed.
He was talking about how obvious a problem is once it declares itself. If someone arrives with a red, swollen, painful chest and a fever, nobody is confused. Everyone knows what that is and what to do about it.
But before that, he said, there is a prodromal phase. You are getting sick, but you are not sick yet.
The word comes from medicine's oldest vocabulary. A prodrome is the early stage of an illness, the part that precedes the signs anyone can point to. The body has begun responding to something. The response has not yet crossed the threshold where our instruments can see it.
Medicine is built around thresholds. A fever is a number. An elevated marker is a number. Redness and swelling are visible. These are good tools, and they work well for the problems they were designed to catch. What they are not built for is the interval before the number moves.
Why the standard workup comes back clean
When you describe vague, systemic symptoms, a clinician usually reaches for the same handful of tests. Dr. Whitfield named them directly, and was blunt about their limits.
C-reactive protein (CRP) rises with significant inflammation. Sed rate (erythrocyte sedimentation rate) is an older, broader inflammation marker. IL-6 is a signalling molecule involved in inflammatory response. All three are useful. All three are also blunt instruments, and in his experience they typically read normal in exactly the situation being described.
His phrasing was that these tests are antiquated, not useless, but not designed for this question. There is no single blood panel you can order that settles it.
A normal result means the test did not detect the thing it measures. It does not mean nothing is happening. Those are different statements, and in a fifteen-minute appointment they collapse into one.
One place this shows up: implants
Before going further, I want to if you have implants and you feel well, this is not a warning about your body. Most people with implant reconstruction respond incredible well fine. This section is here because implants are a clear, well-studied example of the gap described above and not because having them means something is wrong.
What is firmly established is capsular contracture. Your body forms a capsule of scar tissue around any implant; that is normal and expected. In some people that capsule thickens and tightens, and the breast becomes firm, higher-riding, misshapen or painful. It is graded on a four-point scale, it is recognized by every plastic surgeon, and there are established ways to manage it. If this is what you have, you are on well-mapped ground.
There is also BIA-ALCL — breast implant-associated anaplastic large cell lymphoma. It is rare, it is recognized by the FDA, and it has been linked primarily to textured implants. The usual presenting sign is late swelling or fluid collection around the implant, often years after surgery. It is worth knowing the name so you can ask about it directly.
And then there is the territory that is still being worked out. Dr. Whitfield's practice began sending capsule tissue for PCR analysis rather than relying only on traditional culture, on the reasoning that conventional culture requires bacteria to be alive and present in enough quantity to grow, while PCR detects genetic material either way. His published series found bacterial contamination in 29% of samples.
That figure needs its denominator, and he supplied it himself in the interview. It is 29% of the tissue samples from his own patients — people who had already sought him out with problems and had elected to have implants removed. It is not 29% of women with implants. Asked directly whether it could be generalized, he said no, and added that nobody has the population number.
He was equally plain that a positive finding does not establish cause. His words were that we do not know how much it contributes in any individual person.
The honest summary is that this is an area where the science is still catching up with what patients report. Dr. Whitfield said as much, and pointed to a 2025 study from Denmark examining immune cell activity in capsule tissue as the kind of work that will eventually produce better answers.
What you can actually do
Write it down as it happens. Date, symptom, how long, what you were doing, how bad out of ten. A pattern across six weeks is evidence.
Give it a shape before you walk in. One sentence: what changed, when it started, and what you want from this visit. Clinicians are working inside short appointments. A clear opening sentence is not pushiness; it is the most useful gift you can hand them.
Ask the question underneath the answer. When a test comes back normal, a fair follow-up is: what would this test have caught, and what would it miss? It is a real question with a real answer, and it moves the conversation forward instead of ending it.
Keep the whole team informed. If you have implants, make sure your oncologist, your primary care physician and your plastic surgeon are all aware of what you are experiencing. A symptom that looks unremarkable to one of them may matter to another.
A second opinion is a normal thing to seek. If your workup is complete, your symptoms persist, and the conversation has stalled, asking someone else to look is reasonable medical practice. It is not disloyalty to your team.
And if you are weighing removal: that is a surgical decision, with its own risks and its own recovery, to be made with your own team. There is no single correct answer, and anyone who tells you otherwise — in either direction — is overstating what is known.
Read More:
On the Podcast: Breast Cancer Conversations
Episode 283. She Invented Sensation-Preserving Mastectomy—Then Needed It Herself: The Truth About DCIS, Recurrence, and Surgery with Dr. Anne Peled.
